Haem: Thrombosis - aetiology and management Flashcards

1
Q

What is the triad of symptoms in thrombophlebitic syndrome?

A

Recurrent pain

Swelling

Ulcers

also called post-thrombotic syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Factors affecting blood which increase thrombosis risk

A

Viscosity
* high haematocrit
* raised protein/paraprotein

High platelets

coagulation factors
* excess pro-coagulant
* deficient anticoagulant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Virchow’s triad

A

3 contributing factors to thrombosis, disruptions in any of these increase thrombosis risk:

Blood
Vessel wall
Blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Consequences following VTE

A

Death
Recurrence
Thrombophlebitic syndrome
Pulmonary HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Minimum length of anticoagulant treatment following VTE

A

3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What catalyses the conversion of fibrinogen to fibrin?

A

Thrombin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which anticoagulant molecules are expressed on the blood vessel wall?

A

Thrombomodulin

Endothelial protein C receptor

Tissue factor pathway inhibitor

Heparans

NOTE: it does not normally produce tissue factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Is blood vessel wall anti or pro thrombotic

A

normally antithrombotic

But infection (covid 19)/ vasculitis/ trauma/malignancy makes it very promthrombotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Recall 5 effects of inflammation on the blood vessel wall

A
  1. Anticoagulant molecules (e.g. thrombomodulin) are downregulated
  2. TF expressed
  3. Prostacyclin decreased
  4. Adhesion molecules upregulated
  5. VWF released (leading to neutrophil capture, and formation of NETs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which coagulation pathway is mainly implicated in VTE

A

Extrinsic - via tissue factor being exposed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the anticoagulant proteins
What do they target

A

Tissue factor pathway inhibitor (TFPI) - degrades VIIa and Xa

Protein C and Protein S - degrades factor Va, and VIIIa

Antithrombin - degrades Xa and IIa (thrombin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do neutrophils contribute to immunothrombosis?

A

Neutrophils release DNA, which is procoagulant - Neutrophil Extracellular Traps (NETs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

low dose vs high dose anticoagulant indications

A

low dose - prevention
high dose - treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Give 4 ways in which blood stasis promotes thrombosis

A
  1. Accumulation of activated factors
  2. Promotes platelet adhesion
  3. Promotes leukocyte adhesion and transmigration
  4. Hypoxia produces inflammatory effect on endothelium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the broad mechanism of action of heparins?

A

Potentiate antithrombin - which binds to Xa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Give an example of an LMWH

A

Enoxaparin/ Tinzaparin

17
Q

immediate vs delayed anticoagulants

A

delayed - warfarin –> reduces procagulants activity

immediate - Heparins, DOACs –> increases anticoagulant activity

18
Q

heparin methods of administration
what monitoring required

A

unfractionated heparin - IV infusion - monitor

LMWH - subcut - no monitoring

pentasaccharide - subcut - no monitorinh

19
Q

How is unfractionated heparin monitored?

What about LMWH?

A

Unfractionated heparin: it has variable pharmacokinetics and a variable dose-response

Must be monitored with APTT or anti-Xa levels

LMWH: reliable pharmacokinetics so monitoring usually not required

Monitor anti-Xa levels if there is renal failure, extreme weight or extreme risk

20
Q

What are the disadvantages of heparin?

A

Administered by injection

Risk of osteoporosis

Variable renal dependence - renally excreted so monitor in CKD

Risk of heparin-induced thrombocytopaenia

21
Q

How does warfarin affect vit K?

A

Warfarin inhibits vitamin K epoxide reductase

Prevents recycling of Vit K - factor 7 drops the first

delayed action

22
Q

Which procoagulant factors fall as a result of warfarin medication?

A

II, VII, IX and X

*Also impairs Protein C and Protein S (which are natural anticoagulant molecules)*

23
Q

benefits of DOACs

A

no monitoring required
less bleeding risk
no osteoporosis risk
no monitoring required

24
Q

How can the action of warfarin be reversed?

A

Administering vitamin K – takes 12 hours

Giving factors 2, 7, 9 and 10 – immediate

if dietary vitamin K - difficult to anticoagualte

25
mechanism of DOACs
bind to factor Xa dabigatran - binds to factor IIa (thrombin)
26
How is warfarin monitored?
INR = Pro-thrombin time/ standard PT
27
Most common inherited thrombophilia
Factor V Leiden | most unlikely to need any additional management
28
What are the problems with warfarin?
Teratogenic so cannot give during pregnancy Initial hypercoagulable state due to inhibition of protein C and protein S - that's why heparin is co-administered until INR stabilises
29
Primary thromboprophylaxis
Risk assessment for VTE LMWH TED stockings | would also do bleeding risk assessment
30
List some properties of DOACs
Oral administration Immediate action (peak = 3-4 hours) Useful in long-term Short half-life No monitoring needed NOTE: contra-indicated in valvular AF
31
Which DOAC inhibits factor IIa? Which DOACs inhibit factor Xa?
IIa: Dabigatran Xa: Rivaroxiban Apixaban Edoxaban
32
Which surgeries carry the highest risk of thrombosis?
Orthopaedic
33
Which of these factors are associated with a higher risk of recurrence of DVT? Male sex Female sex Proximal thrombosis Distal thrombosis Post surgery Idiopathic
Male sex Proximal thrombosis Idiopathic
34
Risk factors for thrombosis
Cancer Surgery Obesity Elderly Immobility \*Antithrombin deficiency confers the highest risk\*
35
What should all patients \> 60 years old with idiopathic thromboembolic disease be offered?
CT scan to check for an underlying cause
36
Outline the treatment of DVT/PE.
Start LMWH (e.g. tinzaparin 175 u/kg) + warfarin Stop LMWH when INR \> 2 for 2 days ALTERNATIVE: start a doac These should be continued for: - Known cause: 3 months - Unknown cause or cancer VTE: 3-6 months - Thrombophilic/recurrent: lifelong
37
How do you prevent venous thrombosis recurrence?
After a surgical precipitant: no long-term anticoagulation needed After a minor precipitant: 3 months anticoagulation usually adequate If idiopathic cause: long-term anticoagulation (10-20% recurrence within 2 years) | so if there is no obvious cause --> highest risk of recurrence
38
how does dose of anticoagulant change oveer treatment period why
Highest in 1st week then will decrease over the following 3 months clots are meant to extend + become larger when they first form, so need aggressive management intially